Cost effectiveness of adding budesonide/formoterol to tiotropium in COPD in four Nordic countries

BUD/FORM + TIO represents a clinical and economic benefit to health systems and society for the treatment of COPD in the Nordic countries. (ClinicalTrials.gov Identifier: NCT00496470).